Technology Due Diligence for Queen's Park Equity’s Investment in Initiate Consultancy
- Agu Aarna
- 2 days ago
- 2 min read
Intium successfully advised Queen's Park Equity, a UK-based private equity firm, on its investment in Initiate Consultancy. Initiate is a global leader in market access and HEOR consultancy services for clients across the pharmaceutical, medical device, and diagnostic sectors.
Many thanks to Intium for their support on this transaction, who delivered a focused and practical technology review in a timely and efficient manner.
– Mark Crowley, Queen’s Park Equity
Need help on health tech technical due diligence?
Technology Due Diligence Outline
Our objective was to provide Queen's Park Equity with an evaluation of Initiate's technology backbone - specifically, its technical suitability and security of their business operations, as well as its capacity to evolve alongside future growth. We delivered an assessment covering security posture, data management capabilities, platform extensibility, and R&D organization ecosystem health.
In addition to the core scope, our technology due diligence assessed whether existing integration principles were robust and supportive of future extensibility, identifying key risks and opportunities to inform the path forward.
Intium's detailed technology due diligence enabled Queen's Park Equity to invest confidently with a clear understanding of both the upside potential and risks associated with backing Initiate's next growth phase, that will be organic as well as through carefully selected acquisitions.
About Queen's Park Equity
Queen’s Park Equity is a London-based private equity firm focused on scaling and supporting entrepreneur-led businesses. Specializing in middle-market investments, QPE provides both capital and strategic guidance to companies primarily within the Education, Health & Pharma, and Tech & Business Services sectors.
Queen's Park Equity Overview
Headquarters: London, UK
Sector focus: Education, Health & Pharma and Tech Services
Enterprise Value Size: £15 - £100 million
About Initiate Consultancy
Initiate Consultancy is a market access & health economics consultancy specializing in reimbursed access strategies for life‑impacting diseases. Its core business provides tailored solutions across the product lifecycle (including pricing & reimbursement, payer & clinical insights, health technology assessment, evidence synthesis, value communication and launch preparation). Founded on a mission to simplify access and demonstrate value across multiple geographies, Initiate has delivered over 130 HTA submissions, achieving a 98% success rate and supporting 80+ global clients.
Facing a tech investment target?
